KIMS Deepens Sangli Presence with Rs 15 Crore Hospital Stake

• Investment: Rs 15 crore for 6% stake in Ushahkal Abhinav Specialty Hospital LLP.
• Expansion: Target facility currently operates 316 beds with potential to exceed 500 beds.

Reader Takeaway: This strategic capital infusion strengthens KIMS's operational control over an existing partner facility in Sangli, Maharashtra.

What just happened

Krishna Institute of Medical Sciences (KIMS) board approved the acquisition of a 6% stake in Ushahkal Abhinav Specialty Hospital LLP for Rs 15 crore. This investment is being executed via a primary capital infusion into the hospital. The deal is expected to be finalized on or before October 31, 2026. BDO Valuation Advisory LLP provided the valuation for this transaction, which is not classified as a related party deal.

Why this matters

KIMS already manages this facility under the 'KIMS-UAIMS' brand. By taking an equity stake, the company moves from a pure management role to a part-owner, allowing for tighter integration of operational workflows. This move aligns with the company's regional growth strategy in Maharashtra, specifically in the Sangli region, where it aims to scale the facility from 316 to over 500 beds.

The backstory

The target facility has shown consistent top-line growth over the past three fiscal years, with turnover rising from Rs 64.51 crore in FY24 to Rs 80.42 crore in FY26. However, the facility recorded a net loss of Rs 23.59 crore for FY26, highlighting the current need for operational optimization that KIMS aims to drive through this investment.

What to track next

Investors should look for updates on the facility’s capacity expansion towards the 500-bed target and improvements in bottom-line performance for the Ushahkal Abhinav entity. Monitoring the quarterly operational efficiency metrics of the KIMS-UAIMS unit will provide insight into the success of this capital infusion.